contract_awardAwarded Thursday, May 7, 2026Analyzed

ENCORE JV1 LLC: $21.9M Department of Veterans Affairs Contract

Bullish

Summary

ENCORE JV1 LLC, a private entity, won a $21.9M VA contract for contact center staffing support. While not publicly traded, this award signals continued VA investment in veteran experience services, benefiting publicly traded competitors like SAIC, CACI, and Leidos. The contract aligns with bullish healthcare and technology sector momentum from related legislation.

See which stocks are affected

Key takeaways, market implications, full AI analysis, and connected signals are available to HillSignal members.

Already have an account? Log in

Key Takeaways

  • 1.ENCORE JV1 LLC is private, but the contract signals VA's focus on veteran experience, benefiting public competitors SAIC, CACI, and Leidos.
  • 2.The Clinical Trial Modernization Act (S4440) supports this spending trend in healthcare and technology.
  • 3.Pure-play contact center firms like TTEC and Concentrix may see downstream subcontracting opportunities.

Market Implications

The $21.9M contract is small relative to the revenues of SAIC, CACI, and Leidos, but it reinforces a positive spending trend in VA contact center services. These companies have existing VA relationships and could see incremental revenue from follow-on contracts. The Clinical Trial Modernization Act adds legislative tailwinds for healthcare and technology sectors, potentially boosting investor sentiment for these stocks.

Full Analysis

1) The Department of Veterans Affairs awarded ENCORE JV1 LLC a $21.9M definitive contract for Veterans Experience Office Contact Center Staffing Support Services, covering a one-year period from August 2026 to August 2027. This is a service contract focused on staffing and support for VA's contact center operations, which handle veteran inquiries and service delivery. 2) ENCORE JV1 LLC is a private entity not publicly traded. However, the contract signals the VA's commitment to improving veteran experience through contact center modernization. Publicly traded competitors in the federal contact center and IT services space—such as SAIC ($SAIC), CACI ($CACI), and Leidos ($LDOS)—are well-positioned to capture similar contracts. These companies have existing relationships with the VA and expertise in contact center operations, making them indirect beneficiaries of this spending trend. 3) The contract is supported by the Clinical Trial Modernization Act (S4440), which is bullish for healthcare and technology sectors. This bill aims to streamline clinical trials and improve veteran access to care, indirectly boosting demand for VA contact center services that facilitate patient engagement and support. 4) Supply chain beneficiaries include smaller subcontractors specializing in contact center technology and staffing. Companies like TTEC Holdings ($TTEC) and Concentrix ($CNXC) provide contact center solutions and could see downstream demand as the VA expands its contact center capabilities. These firms are more pure-play and could experience outsized stock moves relative to diversified contractors. 5) Historically, VA contact center contracts have been recurring and stable, with multi-year renewals common. The shift to fixed-price contracting under the recent Executive Order on federal contracting could compress margins for cost-plus contractors but benefit firms with strong cost control. This contract's one-year term suggests it may be a bridge or pilot, with potential for expansion if successful.

Intelligence Surface

Cross-referenced against federal contracts, SEC insider filings & congressional trade disclosures

Unconfirmed

No confirming evidence found yet from contracts, insider trades, or congressional activity

$$SAIC▲ Bullish

What the bill does

Competitive displacement and sector spending signal

Who must act

Department of Veterans Affairs awarded ENCORE JV1 LLC a $21.9M contract for contact center staffing support

What happens

This contract signals continued VA investment in contact center services, benefiting competitors like SAIC that have similar capabilities in federal contact center and IT support

Stock impact

SAIC's federal health and civilian segment, which includes VA contracts, could see increased demand as the VA expands contact center operations; SAIC's annual revenue is ~$7.5B, making this contract size small but indicative of a broader trend

$$CACI▲ Bullish

What the bill does

Competitive displacement and sector spending signal

Who must act

Department of Veterans Affairs awarded ENCORE JV1 LLC a $21.9M contract for contact center staffing support

What happens

CACI competes for VA contact center and IT support contracts; this award highlights VA's commitment to modernizing veteran services, potentially leading to more contracts in this space

Stock impact

CACI's expertise in enterprise IT and contact center solutions positions it to capture similar VA contracts; CACI's annual revenue is ~$6.5B, so this contract is small but the trend is positive

Related Presidential Actions

Executive orders & memoranda affecting the same sectors or companies

Exec OrderApr 30, 2026

Promoting Efficiency, Accountability, and Performance in Federal Contracting

This executive order mandates that federal agencies default to using fixed-price contracts for procurement, shifting away from cost-reimbursement models. It requires written justification and senior-level approval for any non-fixed-price contract over certain dollar thresholds (e.g., $10M for most agencies, $100M for the Department of War), and directs agencies to review and renegotiate their 10 largest non-fixed-price contracts within 90 days. The order also tasks OMB with implementation guidance and the Federal Acquisition Regulatory Council with proposing regulatory amendments within 120 days.

Exec OrderApr 18, 2026

Accelerating Medical Treatments for Serious Mental Illness

This executive order directs the FDA to prioritize review and facilitate 'Right to Try' access for psychedelic drugs, including ibogaine compounds, that have received Breakthrough Therapy designation for serious mental illnesses. It also allocates $50 million from HHS to support state programs advancing these treatments and mandates collaboration between HHS, FDA, VA, and the private sector to increase clinical trial participation and data sharing for these drugs. The Attorney General is further directed to expedite rescheduling reviews for approved Schedule I psychedelic substances.

Contract Details

Recipient

ENCORE JV1 LLC

Award Amount

$21,865,645

Awarding Agency

Department of Veterans Affairs

Sub-Agency

Department of Veterans Affairs

Contract Type

DEFINITIVE CONTRACT

Related Bills

S4440